Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Xiamen Yan Palace Bioengineering (XIAMEN HK)
Watchlist
5
Analysis
Health Care
•
China
Xiamen Yan Palace Bioengineering Co. Ltd. manufactures and distributes food supplements. The Company produces freshly stewed bird's nest, dry bird's nest, and other products. Xiamen Yan Palace Bioengineering conducts businesses in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Xiamen Yan Palace Bioengineering
•
27 Nov 2023 08:55
Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit...
Xinyao (Criss) Wang
Follow
345 Views
Share
bearish
•
Xiamen Yan Palace Bioengineering
•
07 Sep 2023 08:55
Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability
Since the efficacy/actual value of EBN is questionable, marketing/promotion alone cannot drive future performance growth.Yan Palace's profit model...
Xinyao (Criss) Wang
Follow
486 Views
Share
bullish
•
JD.com Inc (ADR)
•
25 Jun 2023 06:55
ECM Weekly (25th June 2023) - Tryt, Shiyue Daotian, Keep, SML, HDFC, Shriram, Tata Tech, Doosan, J&T
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
406 Views
Share
bearish
•
Keep Inc
•
21 Jun 2023 13:28
Keep Pre-IPO - Updates Since Our Last Note - Losses Have Been the Only Constant
Keep Inc (KEEP HK) is looking to raise around US$100m in its upcoming Hong Kong IPO. In this note, we discuss the updates since our last note.
Clarence Chu
Follow
367 Views
Share
bullish
•
Xiamen Yan Palace Bioengineering
•
21 Jun 2023 10:32
Xiamen Yan Palace Bioengineering Pre-IPO Tearsheet
Xiamen Yan Palace Bioengineering (1951686D CH) is looking to raise around US$200m in its upcoming Hong Kong IPO. The deal will be run by CICC and...
Clarence Chu
Follow
358 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x